Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Pharmaceutical Discount Contract From 01.10.2025 For The Combination Of Active Ingredients Naproxen And Esomeprazole As Part Of An Open House Procedure 2026-02-15
Germany Conclusion Of Non-exclusive Discount Agreement Pursuant To § 130a Abs. 8 Sgb V On Active Substances (medicines) Vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Finished Medicinal Product Itulazax-vv 86 2026-02-15
Germany Completion Of Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Naloxegol -vv 86, Medicines 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Roxadustat (evrenzo) -vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Tafamidis-vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Combination Glacaprivir/pibrentasvir-vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Ribociclib-vv 86, Medicines 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Rifaximin-vv 86 2026-02-15
Germany Completion Of Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Natalizumab (ilo) -vv 86 2026-02-15
Whats app